EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identifying Predictive Biomarkers of Response in Patients With Rheumatoid Arthritis Treated With Adalimumab Using Machine Learning Analysis of Whole‐Blood Transcriptomics Data

Chuan Fu Yap iD, Nisha Nair, Ann W Morgan, John D Isaacs, Anthony G Wilson iD, Kimme Hyrich, Guillermo Barturen iD, María Riva-Torrubia, Marta Gut, Ivo Gut, Marta E Alarcón Riquelme, Anne Barton und 1 weitere

Arthritis & Rheumatology · 2025-12 · 77 (12) · 1663-1672

DOI: 10.1002/art.43255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 04.08.2025. Verfasst von Chuan Fu Yap und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, The University of Manchester, Manchester, United Kingdom. Hauptthemen laut MEDLINE: Adalimumab, Arthritis, Rheumatoid, Machine Learning, Antirheumatic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taxonomy, Treatment, Targets and Remission Identification of the Molecular Mechanisms of Non-response to Treatments, Relapses and Remission in Autoimmune Infla…, NIHR Newcastle Biomedical Research Centre, Manchester Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Tumornecrosis factor inhibitors (TNFi) have significantly improved rheumatoid arthritis (RA) management, yet variability in patient response remains a substantial challenge, with approximately 40% of patients discontinuing TNFi due to nonresponse or adverse effects. This study aimed to identify biomarkers predictive of adalimumab treatment response using whole‐blood transcriptomics, leveraging machine learning models for data mining observed by targeted statistical analysis.

Methods

A cohort of patients with RA starting TNFi therapy (n = 100) was assessed for treatment response at 6 months, with RNA sequencing performed on baseline (pretreatment) and 3‐month follow‐up samples. Machine learning classifiers were built to identify predictive biomarkers for treatment outcomes. This was observed by a network analysis on the biomarkers to elucidate the most influential biomarker, which was subsequently confirmed through survival analysis.

Results

Differential gene expression analysis in 97 samples passing quality control identified 84 genes associated with treatment response. Random forest classifiers achieved high predictive accuracy with area under the receiver operating characteristic curves up to 0.86, identifying genes contributing to treatment outcomes. Network analysis further elucidated gene interactions, highlighting marginal zone B And B1 cell–specific protein 1 ( MZB1 ) as a novel biomarker not captured by machine learning alone. MZB1's role in B cell development and antibody production was associated with antidrug antibody formation, impacting treatment efficacy.

Conclusion

This study advances the understanding of transcriptomic alterations in RA treatment and enhances our understanding of treatment response mechanisms. Although the gene signatures identified require independent replication, the study serves as a starting point to pave the way for personalized therapeutic strategies in patients commencing TNFi therapy in RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdalimumabArthritis, RheumatoidMachine LearningAntirheumatic AgentsTranscriptomeHumansFemaleMaleMiddle AgedBiomarkersTreatment OutcomeGene Expression ProfilingAdultAged

Substanzen

AdalimumabAntirheumatic AgentsBiomarkers

Autor:innen und Institutionen

  • Centre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, The University of Manchester, Manchester, United Kingdom.
  • Centre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, The University of Manchester and NIHR Biomedical Research Centre Manchester, Manchester, United Kingdom.
  • School of Medicine University of Leeds and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
  • Translational and Clinical Research Institute, Newcastle University and NIHR Newcastle Biomedical Research Centre and Musculoskeletal Unit, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, United…
  • School of Medicine and Medical Science, Conway Institute, University College Dublin, Dublin, Ireland.
  • NIHR Biomedical Research Centre Manchester and Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, The University of Manchester, Manchester, United Kingdom.

ORCID-Profile: Chuan Fu Yap, Anthony G Wilson, Guillermo Barturen

Förderung

  • Taxonomy, Treatment, Targets and Remission Identification of the Molecular Mechanisms of Non-response to Treatments, Relapses and Remission in Autoimmune Infla…
  • NIHR Newcastle Biomedical Research Centre
  • Manchester Biomedical Research Centre
  • NIHR Senior Investigator
  • Versus Arthritis

Zitieren

APA

Yap, C. F., Nair, N., Morgan, A. W., Isaacs, J. D., Wilson, A. G., Hyrich, K., Barturen, G., Riva-Torrubia, M., Gut, M., Gut, I., Alarcón Riquelme, M. E., Barton, A., & Plant, D. (2025). Identifying Predictive Biomarkers of Response in Patients With Rheumatoid Arthritis Treated With Adalimumab Using Machine Learning Analysis of Whole‐Blood Transcriptomics Data. Arthritis & Rheumatology, 77(12), 1663-1672. https://doi.org/10.1002/art.43255

Vancouver

Yap CF, Nair N, Morgan AW, Isaacs JD, Wilson AG, Hyrich K, et al. Identifying Predictive Biomarkers of Response in Patients With Rheumatoid Arthritis Treated With Adalimumab Using Machine Learning Analysis of Whole‐Blood Transcriptomics Data. Arthritis & Rheumatology. 2025;77(12):1663-1672. doi:10.1002/art.43255

BibTeX
@article{Yap2025,
  author = {Yap, Chuan Fu and Nair, Nisha and Morgan, Ann W and Isaacs, John D and Wilson, Anthony G and Hyrich, Kimme and Barturen, Guillermo and Riva-Torrubia, María and Gut, Marta and Gut, Ivo and Alarcón Riquelme, Marta E and Barton, Anne and Plant, Darren},
  title = {Identifying Predictive Biomarkers of Response in Patients With Rheumatoid Arthritis Treated With Adalimumab Using Machine Learning Analysis of Whole‐Blood Transcriptomics Data},
  journal = {Arthritis & Rheumatology},
  year = {2025},
  volume = {77},
  number = {12},
  pages = {1663--1672},
  doi = {10.1002/art.43255}
}
Kostenlos starten →